Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: A study from the UK heart valve registry

European Journal of Cardio-thoracic Surgery

Volumn 14, Issue 2, 1998, Pages 156-164

  Edwards, Maria Benedicta ^a   Ratnatunga, Chandana P ^a   Dore, Caroline J ^b   Taylor, Kenneth M ^a  

^a United Kingdom Heart Valve Registry   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Long term survival; Operative mortality; Prosthetic valve endocarditis

Indexed keywords

ADULT; AGE; AGED; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; ENDOCARDITIS; EXPLANT; FEMALE; GRAFT INFECTION; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; MORTALITY; PRIORITY JOURNAL; REGISTER; REOPERATION; SURVIVAL; UNITED KINGDOM;

BIOPROSTHESIS; ENDOCARDITIS; FEMALE; GREAT BRITAIN; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; REOPERATION; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 0031710579     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00148-1     Document Type: Article

References (27)

1. Antunes M.J. Reoperations on cardiac valves. J Heart Valve Dis. 1:1992;15-28.
2. Bortolotti U., Milano A., Mossuto E., Mazzaro E., Thiene G., Casarotto D. Early and late outcome after reoperation for prosthetic valve dysfunction: analysis of 549 patients during a 26-year period. J Heart Valve Dis. 3:1994;81-87.
3. Bosch X., Pomar J.L., Pelletier L.C. Early and late prognosis after reoperation for prosthetic valve replacement. J Thorac Cardiovasc Surg. 88:1984;567-572.
4. Calderwood S.B., Swinski L.A., Karchmer A.W., Waternaux C.M., Buckley M.J. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 92:1986;776-783.
5. Camacho M.T., Cosgrove D.M. Homografts in the treatment of prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;32-37.
6. David T.E. The Surgical treatment of patients with prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 1:1995;47-53.
7. De Gevigney G., Pop C., Delahaye J.P. The risk of infective endocarditis after cardiac surgical and interventional procedures. Eur Heart J. 16:1995;7-14.
8. Farina G., Vitale N., Piazza L., De Vivo F., de Luca L., Cotrufo M. Long term results of surgery for prosthetic valve endocarditis. J Heart Valve Dis. 3:1994;165-171.
9. Grover F.L., Cohen D.J., Oprian C., Henderson W.G., Sethi G., Hammermeister K.E. Determinants of the occurrence of and survival from prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 108:1994;207-214.
10. Husebye D.G., Pluth J.R., Piehler J.M., Schaff H.V., Orszulak T.A., Puga F.J., Danielson G.K. Reoperation on prosthetic heart valves. J Thorac Cardiovasc Surg. 86:1983;543-552.
11. Jault F., Gandjbakhch I., Rama A., Nectoux M., Bors V., Vaissier E., Nataf P., Pavie A., Cabrol C. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg. 63:1997;1737-1741.
12. Joyce F., Tingleff J., Pettersson G. The Ross Operation in the treatment of prosthetic aortic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;38-46.
13. Kuyvenhoven J.P., van Rijk-Zwikker G.L., Hermans J., Thompson J., Huysmans H.A. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardio-thorac Surg. 8:1994;420-424.
14. Lytle B.W. Surgical treatment of prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;13-19.
15. Lytle B.W. Introduction: prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;1.
16. Lytle B.W., Priest B.P., Taylor P.C., Loop F.D., Sapp S.K., Stewart R.W., McCarthy P.M., Muehrcke D., Cosgrove D.M. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 111:1996;198-210.
17. Lytle BW, Cosgrove DM, Taylor PC, Gill CC, Goormastic M, Golding LR, Stewart RW, Loop FD. Reoperations for valve surgery: perioperative mortality and determinants of risk for 1000 patients, 1958-1984.
18. McGiffin D.C., Galbraith A.J., McLachlan G.J. Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg. 104:1992;511-520.
19. McGiffin D.C., Kirklin J.K. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;25-31.
20. Muehrcke D.D. Fungal prosthetic valve endocarditis. Seminars Thorac Cardiovasc Surg. 7:1995;20-24.
21. Otaki M. Prosthetic valve endocarditis. An analysis of the outcome in 32 cases. ASAIO J. 40:1994;176-180.
22. Pansini S., Ottino G., Forsennati P.G., Serpieri G., Zattera G., Casabona R., Di Summa M., Villani M., Poletti A., Morea M. Reoperations on heart valve prostheses: an analysis of operative risks and late results. Ann Thorac Surg. 50:1990;590-596.
23. Piehler J.M., Blackstone E.M., Bailey K.R., Sullivan M.E., Pluth J.R., Weiss N.G., Brookmeyer R.S., Chandler J.G. Reoperations on prosthetic heart valves: patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg. 109:1995;30-48.
24. Sweeney M.S., Ruel G.J., Denton M.D., Cooley A., Ott D.A., Duncan J.M., Frazier O.H., Livesay J.J. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg. 90:1985;676-680.
25. UK Heart Valve Registry Report, 1994. Crown Copyright, 1996.
26. Vlessis A.A., Khaki A., Grunkenmeuer G.L., Li H.-H., Starr A. Risk and diagnosis and management of prosthetic valve endocarditis: a review. J Heart Valve Dis. 6:1997;443-465.
27. Yu V.L., Fang G.D., Keys T.F., Harris A.A., Gentry L.O., Fuchs P.C., Wagener M.M., Wong E.S. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg. 58:1994;1073-1077.